NCT03404648 - Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions

Prostate Adenocarcinoma

Interventions

DRUG

C-11 choline PET tracer

C-11 choline PET tracer, One dose, totally 12-14 millicurie (mCi), intravenous administration while patient is lying on the table.

DRUG

Gadobutrol

Single dose of Gadavist® (Gadobutrol, Bayer) at no more than 0.1 mmol/kg will be administrated intravenously.

DEVICE

PET/MR scanner

C11-PET/MR and pelvic mpMRI scan for prostate cancer.

Trial Locations (1)

Mayo Clinic in Arizona, Scottsdale